News headlines about Envision Healthcare (NYSE:EVHC) have trended somewhat positive recently, according to Accern. The research group identifies negative and positive media coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Envision Healthcare earned a media sentiment score of 0.12 on Accern’s scale. Accern also assigned news stories about the company an impact score of 46.1996780676006 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
These are some of the news stories that may have effected Accern’s rankings:
- Envision Healthcare Corporation, (NYSE: EVHC) – Investor’s Alert (Beta Factor in Focus) – Stock Watch (stocksnewstimes.com)
- Hot Tickers: Duke Realty Corporation (DRE), Envision Healthcare Corporation (EVHC) – Market Movers (financialqz.com)
- Envision Healthcare (EVHC) Affirms Q4 Guidance, Provides Business & Governance Update – StreetInsider.com (streetinsider.com)
- Envision Healthcare Provides Business & Governance Update (finance.yahoo.com)
- Hot Stock to Track – Envision Healthcare Corporation (NYSE: EVHC) – Alpha Beta Stock (alphabetastock.com)
Envision Healthcare (NYSE:EVHC) traded up $0.40 during trading hours on Thursday, hitting $35.40. The company had a trading volume of 2,257,700 shares, compared to its average volume of 2,050,267. The firm has a market capitalization of $4,230.00, a PE ratio of -23.76, a PEG ratio of 1.01 and a beta of 0.57. Envision Healthcare has a 12-month low of $23.77 and a 12-month high of $73.00. The company has a debt-to-equity ratio of 0.89, a quick ratio of 3.00 and a current ratio of 3.01.
Envision Healthcare (NYSE:EVHC) last issued its quarterly earnings data on Tuesday, October 31st. The company reported $0.73 earnings per share for the quarter, missing the consensus estimate of $0.81 by ($0.08). The business had revenue of $1.99 billion during the quarter, compared to analysts’ expectations of $2.03 billion. Envision Healthcare had a positive return on equity of 4.88% and a negative net margin of 6.39%. The company’s revenue was up 142.0% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.13 earnings per share. sell-side analysts forecast that Envision Healthcare will post 2.49 EPS for the current year.
Envision Healthcare declared that its Board of Directors has authorized a stock repurchase program on Monday, September 18th that allows the company to repurchase $250.00 million in shares. This repurchase authorization allows the company to repurchase up to 4.5% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company’s board believes its stock is undervalued.
A number of equities analysts have commented on EVHC shares. Jefferies Group set a $71.00 target price on Envision Healthcare and gave the company a “buy” rating in a report on Wednesday, November 1st. KeyCorp set a $67.00 price target on Envision Healthcare and gave the company a “buy” rating in a report on Wednesday, November 1st. Cantor Fitzgerald reaffirmed a “hold” rating and issued a $30.00 price target on shares of Envision Healthcare in a report on Tuesday, November 14th. Canaccord Genuity reaffirmed a “buy” rating and issued a $32.00 price target (down previously from $68.00) on shares of Envision Healthcare in a report on Thursday, November 2nd. Finally, Bank of America cut their price target on Envision Healthcare from $72.00 to $60.00 and set a “buy” rating for the company in a report on Monday, October 9th. One research analyst has rated the stock with a sell rating, eight have given a hold rating and nine have given a buy rating to the stock. The company has a consensus rating of “Hold” and an average target price of $40.13.
About Envision Healthcare
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.